Neurogene (NGNE) Provides Update on NGN-401 Gene Therapy Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Neurogene (NGNE) Provides Update on NGN-401 Gene Therapy Trial
(NASDAQ: NGNE) Delayed: 32.25 +0.72 (2.28%)
Previous Close $31.53    52 Week High $ 
Open $32.11    52 Week Low $ 
Day High $32.97    P/E N/A 
Day Low $31.45    EPS $ 
Volume 175,571